Protocol
Tesamorelin (20mg Vial)
Complete dosage protocol and reconstitution guide for Tesamorelin (20mg Vial).
Calculator preset
Run the vial math before tracking.
At ~6.67 mg/mL, 1 unit ~ 66.7 mcg ; 1 mg ~ 15 units and 2 mg ~ 30 units on a U-100 syringe.
01 · At a glance
Quickstart Highlights
Tesamorelin is a synthetic 44-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH) [1] . It stimulates endogenous growth hormone release and raises IGF-1 levels, leading to enhanced lipolysis and metabolic benefits [2] . Tesamorelin is FDA-approved for reducing visceral adipose tissue in HIV-associated lipodystrophy and is studied for metabolic disorders and aging research [3] [4] .
02 · Dosing & reconstitution
Dosing & Reconstitution Guide
A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.
Standard FDA-Approved Protocol (3.0 mL = ~6.67 mg/mL)
2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol).
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
03 · What you'll need
Supplies Needed
Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.
- 12 weeks ≈ 9 vials (161 mg total)
- 16 weeks ≈ 11 vials (217 mg total)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- 8 weeks (6 vials): 18 mL → 2 × 10 mL bottles
- 12 weeks (9 vials): 27 mL → 3 × 10 mL bottles
- 16 weeks (11 vials): 33 mL → 4 × 10 mL bottles
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
- Goal: Reduce visceral adipose tissue and improve lipid profiles through sustained GH/IGF-1 elevation [3] [4] .
- Schedule: Daily subcutaneous injections for 12–26 weeks (extendable to 52 weeks with medical supervision) [3] . Dose: 2 mg (2000 mcg) daily after Week 1 titration.
- Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate measurement.
- Storage: Lyophilized refrigerated; reconstituted refrigerated; avoid freeze-thaw.
Dosing Protocol
- FDA-approved daily dosing approach with tolerability titration.
- Week 1: 1 mg (1000 mcg) once daily to assess tolerability.
- Weeks 2+: 2 mg (2000 mcg) once daily (standard FDA-approved dose) [7] [8] .
- Frequency: Once per day (subcutaneous), preferably in the evening.
- Cycle Length: 12–26 weeks; clinical trials support up to 52 weeks with monitoring [3] .
- Timing: Evening administration recommended; rotate injection sites.
Storage Instructions
- Lyophilized & Reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F)
- Storage: Lyophilized refrigerated; reconstituted refrigerated; avoid freeze-thaw.
- Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.
04 · Good to know
Important Notes
- Practical considerations for consistency and safety.
- Use new sterile insulin syringes for each injection; dispose in a sharps container [10] .
- Rotate injection sites (abdomen at least 2 inches from navel, thighs, upper arms) to reduce local irritation [6] [10] .
- Inject slowly; wait a few seconds before withdrawing the needle.
- Monitor IGF-1 levels periodically due to potent GH stimulation; observe blood glucose in diabetic patients [9] .
- Document daily dose and site rotation to maintain consistency.
05 · How it works
How This Works
Tesamorelin is a synthetic 44-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH) [1] .
It stimulates endogenous growth hormone release and raises IGF-1 levels, leading to enhanced lipolysis and metabolic benefits [2] .
Tesamorelin is FDA-approved for reducing visceral adipose tissue in HIV-associated lipodystrophy and is studied for metabolic disorders and aging research [3] [4] .
The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.
06 · Daily habits
Lifestyle Factors
- Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
- Track body metrics only if they are relevant to the user's goal and approved data sources.
- Use consistent timing and logging habits so adherence data is meaningful.
07 · What to expect
Potential Benefits & Side Effects
- Tesamorelin observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
- This section is not a claim of therapeutic benefit.
08 · Technique
Injection Technique
- Wash hands with soap and water.
- Wipe the vial stopper and chosen site with alcohol, then let both dry.
- Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
- Use the route and needle technique directed by a qualified professional or product instructions.
- For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
- Do not reuse needles or syringes.
- Dispose of sharps in a puncture-resistant container.
- Return stored items promptly to the correct temperature.
- Log dose, site, date, time, inventory change, and any observation.
09 · Evidence
References
Related pages